CN Patent
CN100367948C — 三环-[5.2.1.02.6]-癸-9-基-黄原酸酯的纯立体异构体的制备和由其制成的药物
Assigned to Zhao Yuan Pharmaceutical Co Ltd · Expires 2008-02-13 · 18y expired
What this patent protects
本发明涉及包含外/外-三环-[5.2.1.0 2.6 ]-癸-9-基-黄原酸酯的药物制剂,包含外/外-三环-[5.2.1.0 2.6 ]-癸-9-基-黄原酸酯作为活性成分用于治疗生殖器疱疹、唇疱疹、AIDS、肿瘤或自身免疫疾病的药物,以及制备三环-[5.2.1.0 2.6 ]-癸烷-9-醇和三环-[5.2.1.0 2.6 ]-癸-9-基-黄原酸酯纯立体异构体的方法。
USPTO Abstract
本发明涉及包含外/外-三环-[5.2.1.0 2.6 ]-癸-9-基-黄原酸酯的药物制剂,包含外/外-三环-[5.2.1.0 2.6 ]-癸-9-基-黄原酸酯作为活性成分用于治疗生殖器疱疹、唇疱疹、AIDS、肿瘤或自身免疫疾病的药物,以及制备三环-[5.2.1.0 2.6 ]-癸烷-9-醇和三环-[5.2.1.0 2.6 ]-癸-9-基-黄原酸酯纯立体异构体的方法。
Drugs covered by this patent
- Livtencity (MARIBAVIR) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.